Employers should consider the following 2024 updates to SECURE 2.0; the benefits will serve as a clear differentiator within an increasingly competitive and uncertain economy.

Offering comprehensive, seamless obesity and digestive health support is the best way for employers to address rising costs of both conditions while maximizing their ROI on GLP-1 drugs.

Four million Americans will be turning 65 every year for the next four years, which is why employers need to communicate the in-service distribution option to employees, says Joseph Roop, president, Belmont Capital Advisors.